Daniel V. Santi
Fundador en Prolynx LLC .
Cargos activos de Daniel V. Santi
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Prolynx LLC
 Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Prolynx LLC engages in the development of proprietary drug delivery system for half-life extension of proteins, peptides, and small molecules. Its pipeline includes PLX038, PEG-PARP, IL-15, IL-2, PTH 1-34, GLP-1RA, and QMo IVT. The company was founded by Daniel V. Santi and Gary W. Ashley in 2010 and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | 01/01/2010 | - |
| Fundador | 01/01/2010 | - | |
| Presidente | 01/01/2010 | - |
Historial de carrera de Daniel V. Santi
Antiguos cargos conocidos de Daniel V. Santi.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Presidente | - | 14/02/2006 |
| Fundador | - | 14/02/2006 | |
| Presidente | - | 14/02/2006 | |
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/1974 | 01/01/2001 |
Formación de Daniel V. Santi.
| The State University of New York | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Founder | 2 |
| President | 2 |
| Doctorate Degree | 2 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Prolynx LLC
Prolynx LLC Miscellaneous Commercial ServicesCommercial Services Prolynx LLC engages in the development of proprietary drug delivery system for half-life extension of proteins, peptides, and small molecules. Its pipeline includes PLX038, PEG-PARP, IL-15, IL-2, PTH 1-34, GLP-1RA, and QMo IVT. The company was founded by Daniel V. Santi and Gary W. Ashley in 2010 and is headquartered in San Francisco, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Daniel V. Santi
- Experiencia
